- About Us
- Healthcare Companies
- Pharmacy Solutions
- Healthcare Professionals
- Contact Us
- MyAH Portal
Class 2 Recall
01 Sep 2020
GL Pharma is recalling the above batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution obtained during routine stability testing.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
|PIP Code||Product Description||Livery||Affected Batch|
|6359830||OXYCODONE (OXYLAN) PR TAB 40MG||GL PHARMA||9F119A|
|3726148||OXYCODONE PR TAB 40MG CHAN||GL PHARMA||9F119A|
This product is a Schedule 2 Controlled Drug, so please use the Returns Portal for any recalled stock you may need to return to ensure there is authorisation to return. If you are unable to use the Returns Portal then your Alliance Healthcare driver will have a ‘Specialist Product Recall Book' with them on Wednesday 2nd September and Thursday 3rd September for completion and product uplift AM ONLY. Due to Covid 19, the driver will complete the form on your behalf. They will ask for the quantity of stock you have to return and the name of the pharmacist. The driver will give you a copy of the completed form for your records. If you need to return recalled stock from 4th September and are unable to use the Returns Portal please call Customer Services for authorisation to return.
For medical information enquiries please contact email@example.com
For stock control enquiries please contact firstname.lastname@example.org
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
If you have any questions, then please contact your local Service Centre Customer Services team.